Breast cancer is the leading cause of cancer death in women and is the most common type of cancer among them. Research shows that soybeans contain powerful compounds such as isoflavones and phytoestrogens, which may play an important role in the treatment and prevention of cancer, especially breast cancer. The aim of this study was to investigate the molecular mechanisms underlying the effects of soy on breast cancer treatment using bioinformatics and transcriptomic data analysis. The search resulted in four mRNA microarray datasets (GSE9936, GSE63205, GSE50705, GSE58792). We identified differentially expressed genes (DEGs) by using. Common genes between studies were identified using Venn diagrams, and breast cancer-specific genes were extracted from differentially expressed genes using the GEPIA database. Additionally, GEO analysis and pathway enrichment of DEGs were performed using the DAVID database. In our study, the "cell cycle pathway" was introduced and investigated as an important pathway in this cancer, which is associated with soybean consumption and down-regulated genes such as CDC20, CCNB1, CDC6, MAD2L1, CCNA2, TTK, MCM4, CDC25C, MCM2, and ESPL1. Furthermore, "G2-M checkpoint" and "mutant p53" were from the pathways that have decreased activity with soy consumption. (PI3K)/Akt signaling pathway and epithelial-mesenchymal transition were down-regulated in breast cancer, and in our study up-regulated by soy and its extracts. Overall, the results of this study showed that soy compounds may be an important therapeutic target in the treatment of breast cancer, as they alter the expression of genes effective in this disease.